For help on how to get the results you want, see our search tips.
1464 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Shortages Remove Shortages filter
Maximum residue limits Remove Maximum residue limits filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Fycompa (updated)
perampanel, Epilepsies, Partial
Date of authorisation: 23/07/2012, Revision: 17, Authorised, Last updated: 27/05/2020 -
List item
Human medicine European public assessment report (EPAR): Lenalidomide Accord (updated)
lenalidomide, Multiple Myeloma
Date of authorisation: 20/09/2018,
, 
, Revision: 2, Authorised, Last updated: 27/05/2020
-
List item
Human medicine European public assessment report (EPAR): Imvanex (updated)
modified vaccinia Ankara - Bavarian Nordic (MVA-BN) virus, Smallpox Vaccine
Date of authorisation: 31/07/2013,, 
, Revision: 15, Authorised, Last updated: 27/05/2020
-
List item
Human medicine European public assessment report (EPAR): Fulvestrant Mylan (updated)
fulvestrant, Breast Neoplasms
Date of authorisation: 08/01/2018,, Revision: 2, Authorised, Last updated: 27/05/2020
-
List item
Human medicine European public assessment report (EPAR): Olanzapine Teva (updated)
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 12/12/2007,, Revision: 27, Authorised, Last updated: 27/05/2020
-
List item
Human medicine European public assessment report (EPAR): Jardiance (updated)
empagliflozin, Diabetes Mellitus, Type 2
Date of authorisation: 22/05/2014, Revision: 18, Authorised, Last updated: 26/05/2020 -
List item
Human medicine European public assessment report (EPAR): ellaOne (updated)
ulipristal, Contraception, Postcoital
Date of authorisation: 15/05/2009, Revision: 21, Authorised, Last updated: 26/05/2020 -
List item
Human medicine European public assessment report (EPAR): Onivyde pegylated liposomal (previously known as Onivyde) (updated)
irinotecan hydrochloride trihydrate, Pancreatic Neoplasms
Date of authorisation: 14/10/2016,
, Revision: 5, Authorised, Last updated: 25/05/2020
-
List item
Human medicine European public assessment report (EPAR): Brintellix (updated)
Vortioxetine, Depressive Disorder, Major
Date of authorisation: 18/12/2013, Revision: 14, Authorised, Last updated: 25/05/2020 -
List item
Human medicine European public assessment report (EPAR): Pelgraz (updated)
pegfilgrastim, Neutropenia
Date of authorisation: 21/09/2018,, 
, Revision: 5, Authorised, Last updated: 25/05/2020
-
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan (updated)
efavirenz, emtricitabine, tenofovir disoproxil maleate, HIV Infections
Date of authorisation: 05/09/2017,, Revision: 7, Authorised, Last updated: 25/05/2020
-
List item
Human medicine European public assessment report (EPAR): Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz) (updated)
levodopa, carbidopa, entacapone, Parkinson Disease
Date of authorisation: 11/11/2013, Revision: 7, Authorised, Last updated: 25/05/2020 -
List item
Human medicine European public assessment report (EPAR): Rasagiline Mylan (updated)
rasagiline tartrate, Parkinson Disease
Date of authorisation: 04/04/2016,, Revision: 3, Authorised, Last updated: 25/05/2020
-
List item
Human medicine European public assessment report (EPAR): Darunavir Mylan (updated)
darunavir, HIV Infections
Date of authorisation: 03/01/2017,, Revision: 7, Authorised, Last updated: 25/05/2020
-
List item
Human medicine European public assessment report (EPAR): Ferriprox (updated)
Deferiprone, beta-Thalassemia, Iron Overload
Date of authorisation: 25/08/1999, Revision: 27, Authorised, Last updated: 20/05/2020 -
List item
Human medicine European public assessment report (EPAR): Olanzapine Apotex (updated)
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 10/06/2010,, Revision: 10, Authorised, Last updated: 20/05/2020
-
List item
Human medicine European public assessment report (EPAR): Ongentys (updated)
opicapone, Parkinson Disease
Date of authorisation: 24/06/2016,, Revision: 5, Authorised, Last updated: 20/05/2020
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Mylan (updated)
clopidogrel hydrochloride, Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 21/09/2009,, Revision: 15, Authorised, Last updated: 20/05/2020
-
List item
Human medicine European public assessment report (EPAR): Elmiron (updated)
pentosan polysulfate sodium, Cystitis, Interstitial
Date of authorisation: 02/06/2017, Revision: 10, Authorised, Last updated: 20/05/2020 -
List item
Human medicine European public assessment report (EPAR): Waylivra (updated)
Volanesorsen sodium, Hyperlipoproteinemia Type I
Date of authorisation: 03/05/2019,, , 
, Revision: 2, Authorised, Last updated: 19/05/2020
-
List item
Human medicine European public assessment report (EPAR): Stalevo (updated)
levodopa, carbidopa, entacapone, Parkinson Disease
Date of authorisation: 17/10/2003, Revision: 26, Authorised, Last updated: 19/05/2020 -
List item
Human medicine European public assessment report (EPAR): Verkazia (updated)
ciclosporin, Conjunctivitis, Keratitis
Date of authorisation: 06/07/2018,
, , Revision: 3, Authorised, Last updated: 19/05/2020
-
List item
Human medicine European public assessment report (EPAR): Lopinavir/Ritonavir Mylan (updated)
lopinavir/ritonavir, HIV Infections
Date of authorisation: 14/01/2016,, Revision: 9, Authorised, Last updated: 19/05/2020
-
List item
Human medicine European public assessment report (EPAR): Namuscla (updated)
mexiletine hcl, Myotonic Disorders
Date of authorisation: 18/12/2018,, Revision: 2, Authorised, Last updated: 19/05/2020
-
List item
Human medicine European public assessment report (EPAR): Ontruzant (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 15/11/2017,, , Revision: 5, Authorised, Last updated: 19/05/2020